Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2026-03-02 Declaration of Voting R…
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a standard 'Total Voting Rights' announcement issued by EKF Diagnostics Holdings plc in accordance with the FCA's Disclosure and Transparency Rules. It provides the total number of shares and voting rights to assist shareholders in calculating their notification obligations. This type of regulatory disclosure regarding share capital and voting rights is classified as a general regulatory filing (RNS) as it does not fit into specific categories like share issuance or director dealings.
2026-03-02 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the purchase of 141,000 ordinary shares to be held in treasury, provides transaction specifics (price, volume, venue), and includes a PDMR (Person Discharging Managerial Responsibilities) dealing notification for a director. While it contains PDMR information, the primary purpose of the filing is the announcement of the company's own share repurchase activity. Therefore, it is classified as a Transaction in Own Shares (POS).
2026-02-27 English
Share Buyback Programme
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding the initiation of a share buyback programme. It details the intent to repurchase shares, the appointment of a broker to manage the process, and the regulatory context (UK Market Abuse Regulation). While it mentions share repurchases, it is an announcement of a future programme rather than a report of specific transactions already completed (which would be POS). Therefore, it is classified as a regulatory filing/announcement regarding corporate activity.
2026-02-19 English
Share Buyback & Completion of Buyback Programme
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding the completion of a share buyback programme and the purchase of its own shares. It includes detailed tables of the transactions, the impact on total voting rights, and a specific PDMR (Person Discharging Managerial Responsibilities) dealing notification for a director. While it contains PDMR information, the primary purpose of the filing is the announcement of the company's share buyback activity. According to the filing definitions, 'Transaction in Own Shares' (POS) is the most accurate category for company share repurchases.
2026-02-02 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a 'Share Buyback' program. It details the purchase of 106,000 ordinary shares, provides a breakdown of transaction prices and volumes, and includes a PDMR (Person Discharging Managerial Responsibilities) dealing notification for a director. While it contains PDMR information, the primary purpose of the filing is to report the company's repurchase of its own shares, which falls under the 'Transaction in Own Shares' (POS) category.
2026-01-30 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings plc regarding a share buyback program. It details the purchase of 72,000 ordinary shares to be held in treasury, provides transaction breakdowns, and includes a PDMR (Person Discharging Managerial Responsibilities) notification regarding a director's disposal of shares. While it contains PDMR information, the primary purpose of the filing is the announcement of the company's own share repurchase activity. Therefore, it is classified as a 'Transaction in Own Shares' (POS).
2026-01-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.